Selected parameters of antioxidant capacity in renal allograft recipients;Wybrane wskaźniki systemu przeciwutleniaja̧cego u biorców allogennej nerki

Polskie Archiwum Medycyny Wewnetrznej

Volumn 105, Issue 1, 2001, Pages 19-27

  Juskowa, Joanna ^a   Pa̧czek, Leszek ^a   Laskowska Klita, Teresa ^a   Rancewicz, Zofia ^a   Gajewska, Joanna ^a   Jedynak Ołdakowska, Urszula ^a  

^a NONE

Author keywords

Antioxidative capacity; Kidney transplantation; Lipids; Oxydative stress

Indexed keywords

ANTIOXIDANT; FREE RADICAL; MALONALDEHYDE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIOXIDANTS; FEMALE; FREE RADICALS; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035231921     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Knight J.A.: Diseases related to oxygen - derived free radicals. Am. Clin. Lab. Sci., 1995, 25, 111.
2. Esterbauer H., Gebicki J., Puhl H., Jürgens G.: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med., 1992, 13, 341.
3. Witztum J.L., Steinberg D.: Role off oxidized low-density lipoprotein in atherosclerosis J. Clin. Invest., 1991, 88, 1785.
4. Gajewska J., Szczypka M., Pych K. i wsp.: Glutatione s-transferase izoenzymes and glutathione in renal cell carcinoma and kidney tissue. Neoplasma, 1995, 42, 4, 167.
5. Janero D.R.: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad. Biol. Med., 1990, 9, 515.
6. Dasgupta A., Malhotra D., Levy H. i wsp.: Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critical ill patients. Life Sci., 1997, 60, 335.
7. Akihiro Ishiyama, Keüchiro Atarashi, Mayumi Minami i wsp.: Role of free radicals in the pathogenesis of lipid-induced glomerulosclerosis in rats. Kidney Int., 1999, 55, 1348.
8. Ohara Y., Peterson T.E., Harrison D.G.: Hypercholesterolemia increases endothelial superoxide anion production J. Clin. Invest., 1993, 91, 2546.
9. Ross R.: Cell biology of atherosclerosis Ann. Rev. Physiol., 1995, 57, 791.
10. Berliner J.A., Nawab M., Fogelman A.M. i wsp.; Atheroslerosis. Basic mechanism: oxidation, inflamation and genetics. Circulation, 1995, 91, 2488.
11. Schneider A., Hainloth A. i wsp.: Lp(a) and LDL induce apoptosis in rabbit aorta. Role of oxidative stress. Kidney Int., 1999, 55, 1450.
12. Lee H.S., Kim Y.S.: Identification of oxidized low-density lipoprotein in human renal biopsies. Kidney Int., 1998, 54, 848.
13. Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A.: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes, 1994, 43, 1010.
14. Garvin P.Y., Niehoff M.L., Robinson S.M. i wsp.: Renoprotective effects of the 21-aminosteroid U74389G in ischemia - reperfusion injury and cold storage preservation. Transplantation, 1997, 63, 194.
15. Odetti P., Garibaldi S., Gurreri G. i wsp.: Protein oxidation in hemodialysis and kidney transplantation. Metabolism, 1996, 45, 1319.
16. Luciak M., Trznadel K.: Free oxygen species metabolism during hemodialysis with different membranes. Nephrol. Dial Transplant., 1991, 6 (suppl. 3), 66.
17. Cristol J.P., Vela C., Maggi M.F. i wsp.: Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation, 1998, 65, 1322.
18. Islam S.I., Ezeamuzie C.I., Shaheen F.A.M. i wsp.: The impact of long-term cyclosporin-A therapy and biochemical profile in renal transplant patients. J. Clin. Pharmacol. Therap., 1994, 33, 315.
19. McGrath L.T., Treacy R., Mc Clean E., Brown J.H.: Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin. Chem. Acta, 1997, 264, 1.
20. Juskowa J., Pa̧czek L., Barańska E. i wsp.: Lipid peroxidation in renal allograft recipients (RAR). Transplant Proc., 1996, 28, 3474.
21. Satoh K.: Lipid peroxidation in human plasma. Clin. Chim. Acta, 1979, 90, 37.
22. Beers R.R., Sizer I.W: A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem., 1952, 159, 133.
23. Saville B.: A scheme for the colorimetric determination of microgram amount of thiols. Analyst, 1958, 83, 670.
24. Wayner D.D.M., Burton G.W., Inglod K.V., Locke S.: Quantitative measurement of the total peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett., 1985, 187, 33.
25. Driskell W.I., Neese J., Bryant C.C., Bashor M. M.: Measurement of vitamin A and vitamin B in human serum by high-performance liquid chromatography. J. Chrom., 1982, 231, 439.
26. Dorpel M.A., Ghanem H., Rischen-Vos J. i wsp.: Conversion from cyclosporine A treatment improves LDL oxidation in kidney transplant recipients. Kidney Int., 1997, 51, 1608.
27. Kobashigawa J.A., Kasiske B.L.: Hyperlipidemia in solid organ transplantation, 1997, 63, 331.
28. Appanay D.C., Neylan J.F., Ragab M.S. i wsp.: Cyclosporine increases the oxidazibility of low-denisity lipoproteins in renal transplant recipients. Transplantation, 1994, 58, 663.
29. Levinson S.S., Hobbs G.A.: Optimized automated apolipoprotein A-I assays as markers for coronary artery disease. Arch. Pathol. Lab. Med., 1997, 121, 678.
30. Attman P.O. A., Samuelsson O.G., Moberly J. i wsp.: Apolipoproteina B-containing lipoproteins in renal failure. The relation to mode of dialysis. Kidney Int., 1999, 55, 1536.
31. Hussein O., Rosenblat M., Refael G., Aviram M.: Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation, 1997, 63(5), 679.
32. Durak I., Karabacak H.I., Büyükkocak S. i wsp.: Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine (Protective effects of vitamins E and C). Nephron, 1998, 78, 207.
33. Perez de Lama G., Parra T., Arriba G. i wsp.: Reactive oxygen species mediates the effects of cyclosporine A on human cultured mesangial cells [Abstract]. Book of Abstracts XVI International Congress of the Transplantation Society, Barcelona, Spain, 1999, 469.
34. Diederich D., Skopec J., Diederich A. i wsp.: Cyclosporine produces endothellial dysfunction by increased production of superoxide. Hypertension, 1994, 23, 957.
35. Kang M.Y., Tsuchiya M., Packer L., Manabe M.: In vitro study on antioxidant potential of various drugs in the perioperative period. Acta Anaesthesoid Scan., 1998, 42, 4.